West Jefferson, OH – According to filings with the U.S. Securities and Exchange Commission, AmplifyBio is raising $80,000,000.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, J. Kelly Ganjei played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About AmplifyBio

Our mission is to create pathways for novel treatment advances, cutting-edge technologies, and new research frontiers to advance medical breakthroughs, treatments, and cures for disease. AmplifyBio is a new venture that combines the strength and experience of our multi-disciplinary teams with the backing of leading financial partners to advance translational science, cell and gene therapies and next-generation medicines for the benefit of millions of people around the world. Our facilities include a purpose-built GLP lab with 200,000 square feet of space and room for immediate and long-term expansion. Our capabilities include a full complement of pre-clinical models and support services.

To learn more about AmplifyBio, visit http://www.amplify-bio.com/

Contact:
J. Kelly Ganjei, President and Chief Executive Officer
833-641-2006
https://www.linkedin.com/in/kganjei/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved